168 related articles for article (PubMed ID: 38691867)
61. Systemic treatment of advanced or recurrent biliary tract cancer.
Zhang W; Zhou H; Wang Y; Zhang Z; Cao G; Song T; Zhang T; Li Q
Biosci Trends; 2020 Nov; 14(5):328-341. PubMed ID: 32830166
[TBL] [Abstract][Full Text] [Related]
62. Current opinion in otolaryngology and head and neck surgery: clival chordoma and its management.
Snyderman CH; Gardner PA
Curr Opin Otolaryngol Head Neck Surg; 2020 Apr; 28(2):118-121. PubMed ID: 32102007
[TBL] [Abstract][Full Text] [Related]
63. Management and outcome of chordomas in the pediatric population: The Hospital for Sick Children experience and review of the literature.
Tsitouras V; Wang S; Dirks P; Drake J; Bouffet E; Hawkins C; Laughlin S; Rutka JT
J Clin Neurosci; 2016 Dec; 34():169-176. PubMed ID: 27590862
[TBL] [Abstract][Full Text] [Related]
64. Development of transplantable human chordoma xenograft for preclinical assessment of novel therapeutic strategies.
Bozzi F; Manenti G; Conca E; Stacchiotti S; Messina A; Dagrada G; Gronchi A; Panizza P; Pierotti MA; Tamborini E; Pilotti S
Neuro Oncol; 2014 Jan; 16(1):72-80. PubMed ID: 24366975
[TBL] [Abstract][Full Text] [Related]
65. B7-H3 as a Target for CAR-T Cell Therapy in Skull Base Chordoma.
Long C; Li G; Zhang C; Jiang T; Li Y; Duan X; Zhong G
Front Oncol; 2021; 11():659662. PubMed ID: 34868903
[TBL] [Abstract][Full Text] [Related]
66. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.
Ascierto PA; Atkins M; Bifulco C; Botti G; Cochran A; Davies M; Demaria S; Dummer R; Ferrone S; Formenti S; Gajewski TF; Garbe C; Khleif S; Kiessling R; Lo R; Lorigan P; Arthur GM; Masucci G; Melero I; Mihm M; Palmieri G; Parmiani G; Puzanov I; Romero P; Schilling B; Seliger B; Stroncek D; Taube J; Tomei S; Zarour HM; Testori A; Wang E; Galon J; Ciliberto G; Mozzillo N; Marincola FM; Thurin M
J Transl Med; 2015 Nov; 13():374. PubMed ID: 26619946
[TBL] [Abstract][Full Text] [Related]
67. The role of tumor immune microenvironment in chordoma: promising immunotherapy strategies.
Xu J; Shi Q; Wang B; Ji T; Guo W; Ren T; Tang X
Front Immunol; 2023; 14():1257254. PubMed ID: 37720221
[TBL] [Abstract][Full Text] [Related]
68. Chordoma.
Casali PG; Stacchiotti S; Sangalli C; Olmi P; Gronchi A
Curr Opin Oncol; 2007 Jul; 19(4):367-70. PubMed ID: 17545801
[TBL] [Abstract][Full Text] [Related]
69. Endoscopic Approach to Clival Chordomas: The Northwestern Experience.
Rahme RJ; Arnaout OM; Sanusi OR; Kesavabhotla K; Chandler JP
World Neurosurg; 2018 Feb; 110():e231-e238. PubMed ID: 29104156
[TBL] [Abstract][Full Text] [Related]
70. High-resolution whole-genome analysis of skull base chordomas implicates FHIT loss in chordoma pathogenesis.
Diaz RJ; Guduk M; Romagnuolo R; Smith CA; Northcott P; Shih D; Berisha F; Flanagan A; Munoz DG; Cusimano MD; Pamir MN; Rutka JT
Neoplasia; 2012 Sep; 14(9):788-98. PubMed ID: 23019410
[TBL] [Abstract][Full Text] [Related]
71. Prognostic Value of a Category Based on Electron Microscopic Features of Clival Chordomas.
Bai J; Zhai Y; Wang S; Gao H; Du J; Wang J; Li M; Li C; Gui S; Zhang C; Sun Y; Zhang Y
World Neurosurg; 2017 Mar; 99():282-287. PubMed ID: 27916725
[TBL] [Abstract][Full Text] [Related]
72. Operative nuances and surgical limits of the endoscopic approach to clival chordomas and chondrosarcomas: A single-center experience of 72 patients.
Ceylan S; Emengen A; Caklili M; Ergen A; Yılmaz E; Uzuner A; Icli D; Cabuk B; Anik I
Clin Neurol Neurosurg; 2021 Sep; 208():106875. PubMed ID: 34388599
[TBL] [Abstract][Full Text] [Related]
73. New insights into the pharmacological, immunological, and CAR-T-cell approaches in the treatment of hepatocellular carcinoma.
Dal Bo M; De Mattia E; Baboci L; Mezzalira S; Cecchin E; Assaraf YG; Toffoli G
Drug Resist Updat; 2020 Jul; 51():100702. PubMed ID: 32371296
[TBL] [Abstract][Full Text] [Related]
74. Immunohistochemical markers predicting long-term recurrence following clival and spinal chordoma resection: a multicenter study.
Ghaith AK; Akinduro OO; Alexander AY; Goyal A; Bon-Nieves A; de Macedo Filho L; Otamendi-Lopez A; Nathani KR; Abode-Iyamah K; Jentoft ME; Bendok BR; Clarke MJ; Link MJ; Van Gompel JJ; Quiñones-Hinojosa A; Bydon M
Neurosurg Focus; 2023 Jun; 54(6):E15. PubMed ID: 37552641
[TBL] [Abstract][Full Text] [Related]
75. Pediatric Clival Chordoma: A Curable Disease that Conforms to Collins' Law.
Rassi MS; Hulou MM; Almefty K; Bi WL; Pravdenkova S; Dunn IF; Smith TR; Al-Mefty O
Neurosurgery; 2018 May; 82(5):652-660. PubMed ID: 28521059
[TBL] [Abstract][Full Text] [Related]
76. Proton radiation therapy for chordomas and chondrosarcomas of the skull base.
Hug EB; Slater JD
Neurosurg Clin N Am; 2000 Oct; 11(4):627-38. PubMed ID: 11082173
[TBL] [Abstract][Full Text] [Related]
77. Response to imatinib plus sirolimus in advanced chordoma.
Stacchiotti S; Marrari A; Tamborini E; Palassini E; Virdis E; Messina A; Crippa F; Morosi C; Gronchi A; Pilotti S; Casali PG
Ann Oncol; 2009 Nov; 20(11):1886-94. PubMed ID: 19570961
[TBL] [Abstract][Full Text] [Related]
78. Surgical Outcomes of Clival Chordoma Through Endoscopic Endonasal Approach: A Single-Center Experience.
Chen G; Li M; Xu W; Wang X; Feng M; Wang R; Liu X
Front Endocrinol (Lausanne); 2022; 13():800923. PubMed ID: 35464053
[TBL] [Abstract][Full Text] [Related]
79. [From bench to bedside for new treatment paradigms in chordomas: An update].
Méry B; Rowinski E; Guinand M; Benna M; Bousarsar A; Bosacki C; Vallard A; Magné N
Bull Cancer; 2020 Jan; 107(1):129-135. PubMed ID: 31882268
[TBL] [Abstract][Full Text] [Related]
80. Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury.
Magnaghi P; Salom B; Cozzi L; Amboldi N; Ballinari D; Tamborini E; Gasparri F; Montagnoli A; Raddrizzani L; Somaschini A; Bosotti R; Orrenius C; Bozzi F; Pilotti S; Galvani A; Sommer J; Stacchiotti S; Isacchi A
Mol Cancer Ther; 2018 Mar; 17(3):603-613. PubMed ID: 29237806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]